Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Capital/Financing Update 2017

Jan 11, 2017

5250_prs_2017-01-11_95b17d00-39ed-4dcf-8dc2-87011785a4f5.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

11 January 2017

REGISTRATION DOCUMENT SUPPLEMENT

SUPPLEMENT 4/2016

BARCLAYS BANK PLC (Incorporated with limited liability in England and Wales)

Pursuant to the Global Structured Securities Programme

______________________________________________________________

This supplement dated 11 January 2017 (the "Supplement") is supplemental to and must be read in conjunction the registration document 3/2016 dated 1 June 2016, as supplemented by (a) Supplement 1/2016 dated 15 August 2016, (b) Supplement 2/2016 dated 21 November 2016 and (c) Supplement 3/2016 dated 20 December 2016 (the "Registration Document") of Barclays Bank PLC in its capacity as issuer (the "Issuer") in respect of its Global Structured Securities Programme (the "Programme"). This Supplement constitutes a supplement for the purposes of Directive 2003/71/EC (and amendments thereto) and Section 87G of the UK Financial Services and Markets Act 2000 ("FSMA").

Terms defined in the Registration Document shall, unless the context otherwise requires, have the same meaning when used in this Supplement.

The purpose of this Supplement is to supplement (i) the "Information Incorporated by Reference" and "The Issuer and the Group" sections of the Registration Document following the filing of the 23 December 2016 Form 6-K (as defined in the section "Information Incorporated by Reference" below) with the United States Securities and Exchange Commission (the "SEC") and (ii) the "The Issuer and the Group" section of the Registration Document to reflect the change in name from Barclays Corporate & International" to "Barclays International".

(A) INFORMATION INCORPORATED BY REFERENCE

The "Information Incorporated by Reference" section of the Registration Document is supplemented by:

  • (i) adding to the list of documents incorporated by reference the joint announcement of Barclays PLC and the Issuer relating to the complaint filed by the United States Department of Justice, as filed with the SEC on Form 6-K on 23 December 2016 (the "23 December 2016 Form 6-K").
  • (ii) adding the following page references in respect of the 23 December 2016 Form 6-K to the cross-reference lists:

From the 23 December 2016 Form 6-K

Exhibit 99.1 - Barclays PLC announcement "Complaint filed by United States Department of Justice", dated December 22, 2016. Page 4

Only information listed in the cross-reference list above is incorporated by reference into the Registration Document.

For the purposes of the prospectus rules made under Section 73A of the FSMA and the Registration Document, the information incorporated by reference, either expressly or implicitly, into the 23 December 2016 Form 6-K does not form any part of the Registration Document.

Information in the 23 December 2016 Form 6-K which is not incorporated by reference into the Registration Document is either not relevant for the investor or is covered elsewhere in the Registration Document.

The 23 December 2016 Form 6-K may be inspected during normal business hours at the registered office of the Issuer or at https://www.home.barclays/barclays-investorrelations/results-and-reports/results.html.

(B) THE ISSUER AND THE GROUP

(i) The "The Issuer and the Group" section of the Registration Document is supplemented as follows:

The words "Barclays Corporate & International" in the fifth and seventh line respectively of the second paragraph on page 23 are replaced with the words "Barclays International".

(ii) The "The Issuer and the Group" section of the Registration Document is supplemented by deleting the sentence under "Legal Proceedings" and replacing it with the following:

"For a description of the governmental, legal or arbitration proceedings that the Issuer and the Group face, see (i) Note 13 (Provisions) and Note 19 (Legal, competition and regulatory matters) to the financial statements of Barclays PLC on pages 79 to 80 and pages 83 to 94, respectively, of the Q2 2016 Interim Results Announcement, (ii) page 9 of the Q3 2016 Results under the section entitled "Other matters" for a description of the updated provisions for the payment protection insurance redress and (iii) page 4 of the 23 December 2016 Form 6-K."

To the extent that there is any inconsistency between (a) any statement in this Supplement and (b) any other statement in, or incorporated by reference in the Registration Document, the statements in (a) above shall prevail.

Investors should be aware of their rights under Section 87Q(4) to (6) of the Financial Services and Markets Act 2000. Investors who have agreed to purchase or subscribe for Securities before this Supplement was published have the right, exercisable within two working days after the date on which this Supplement is published, to withdraw their acceptances. Such right shall expire on 13 January 2017. Investors should contact the distributor from which they agreed to purchase or subscribe the Securities in order to exercise their withdrawal rights.

References to the Registration Document shall hereafter mean the Registration Document as supplemented by this Supplement. The Issuer has taken all reasonable care to ensure that the information contained in the Registration Document, as supplemented by this Supplement is, to the best of its knowledge, in accordance with the facts and contains no omission likely to affect its import and accepts responsibility accordingly.

This Supplement has been approved by the United Kingdom Financial Conduct Authority, which is the United Kingdom competent authority for the purposes of the Prospectus Directive and the relevant implementing measures in the United Kingdom, as a supplement issued in compliance with the Prospectus Directive and the relevant implementing measures in the United Kingdom for the purpose of giving information with regard to the Issuer.

The date of this Supplement is 11 January 2017